Funding Rounds
Cerecin

Accera Series B round

Cerecin

Cerecin, formerly Accera, is a company that looks to develop therapeutic drugs for neurodegenerative diseases.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $7.50M

Raised Date: 2006-08-16